Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

Delayed Quote. Delayed Nasdaq - 08/29 04:00:02 pm
93.57 USD   +0.83%
5d ago VERTEX PHARMACEUTICALS : Saskatchewan to cover expensive cystic fibrosis dr..
5d ago NASDAQ 100 MOVERS : Vip, vrtx
08/22 VERTEX PHARMACEUTICALS : Assigned Patent
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/25/2014 08/26/2014 08/27/2014 08/28/2014 08/29/2014 Date
91.76(c) 93.64(c) 93.03(c) 92.8(c) 93.57(c) Last
971 946 1 899 755 837 012 558 165 723 167 Volume
+1.71% +2.05% -0.65% -0.25% +0.83% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs. The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
10/27Earnings Release
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 556 M
EBIT 2014 -655 M
Net income 2014 -706 M
Finance 2014 427 M
Yield 2014 -
Sales 2015 1 395 M
EBIT 2015 110 M
Net income 2015 42,9 M
Finance 2015 935 M
Yield 2015 -
PER 2014 -
PER 2015 547,83
EV / Sales 2014 39,3x
EV / Sales 2015 15,3x
Capitalization 22 277 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
5d ago VERTEX PHARMACEUTICALS : Saskatchewan to cover expensive cystic fibrosis drug
5d ago NASDAQ 100 MOVERS : Vip, vrtx
08/22 VERTEX PHARMACEUTICALS : Assigned Patent
08/20 VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Solid Forms of ..
08/20 VERTEX PHARMACEUTICALS : Patent Issued for Isothiazolopyridinones Useful for the..
08/15 VERTEX PHARMACEUTICALS : Assigned Patent
08/13 Biotechs lift Wall Street; Dow back in black for 2014
08/13DJMARKET SNAPSHOT : U.S. Stocks Push Higher; Biotechs Rally
08/13 VERTEX PHARMACEUTICALS : New Findings on Medicinal Chemistry Described by Invest..
08/11 S&P 500 MOVERS : Vrtx, kmi
08/11 NASDAQ 100 MOVERS : Ilmn, tsla
08/08 VERTEX PHARMACEUTICALS : Assigned Patent
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Vertex Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF